Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2/3 1

Status

Terminated 3

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other 3

Conditions

Opioid-Induced Constipation 3Constipation 3

Interventions

alvimopan 6tegaserod 3naloxegol 2Standard of Care 2Naloxone 2polyethylene glycol 3350 1oxycodone-acetaminophen 1oxycodone naloxone combination 1naldemedine 1methylnaltrexone 1ma zi ren wan 1isatuximab 1Videotape Recording 1Tramadol 1Sutures 1Surveys and Questionnaires 1Surgical Instruments 1Sennosides 1Quality of Life 1Proteins 1Phenolphthalein 1Oxycodone 1Orphenadrine 1Octreotide 1Nicotine 1Morphine 1Methadone 1Lidocaine 1Ketorolac Tromethamine 1Ketorolac 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Constipation × tegaserod × Clear all
NCT00399659 2012-05-01

Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.

Novartis

Phase 3 Terminated
360 enrolled
Other

Opioid-Induced Constipation, Constipation

NCT00365820 2012-04-20

Efficacy and Safety of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain

Novartis

Phase 2/3 Terminated
670 enrolled
Other

Opioid-Induced Constipation, Constipation

NCT00414024 2012-04-20

Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.

Novartis

Phase 3 Terminated
11 enrolled
Other

Opioid-Induced Constipation, Constipation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡